With increasing interest in the mechanisms underpinning improved immunotherapy treatment of NSCLC [21, 22, 23], a baseline overview of immune cell infiltration (lymphocytic‐CD3 and myeloid‐CD11b markers) was performed to compare across the unifocal models tested (Figure 5A–D). The gene discussed is ITGAM; the disease is non-small cell lung carcinoma.